碳离子放疗对早期肺癌的相对生物学效应
该研究基于9个队列394例早期肺癌碳离子放疗患者的临床结局数据,采用机制性肿瘤反应模型估算碳离子放疗相对于光子放疗的相对生物学效应(RBE)。拟合参数与碳离子体外放射生物学一致,推导出的RBE随分次剂量增大和分次数减少而从2.1降至1.5。
要点
- 基于394例早期肺癌碳离子放疗数据估算RBE范围为2.1至1.5。
- RBE随分次剂量增大和分次数减少而降低。
- 拟合参数与碳离子体外放射生物学已知特征一致。
核心结论
- 拟合的放射生物学参数与已知碳离子体外放射生物学一致,剂量响应曲线在广泛剂量分次方案下良好拟合报告数据。
- 同一模型仅用少数具有明确机制意义的拟合参数即可综合光子放疗与碳离子放疗在早期肺肿瘤中的临床经验。
研究设计与样本
- 纳入所有已发表的9个患者队列共394例接受碳离子放疗的早期肺癌患者临床结局数据。
- 使用先前在肺癌光子放疗中验证的机制性肿瘤反应模型,基于分次剂量、分次数、治疗日程和局部控制率进行模拟。
- 拟合四个参数:α、α/β、仅能获取葡萄糖而非氧的细胞的氧增强比(OERI)和因饥饿而死亡的细胞的氧增强比(OERH)。
主要发现
- 碳离子放疗最佳拟合参数:α=1.12 Gy-1(95%CI:0.97-1.26),α/β=23.9 Gy(95%CI:8.9-38.9)。
- 缺氧细胞群的氧诱导放射抵抗特征为OERI=1.08(95%CI:1.00-1.41,缺乏氧但非葡萄糖的细胞)和OERH=1.01(95%CI:1.00-1.44,缺乏氧和葡萄糖的细胞)。
- 推导出的RBE取决于剂量和分次方案,范围为2.1至1.5,分次剂量越大、分次数越少则RBE值越低。
关键数值与推荐
- 碳离子放疗相对光子放疗的RBE范围为2.1至1.5,取决于剂量和分次方案。
- α=1.12 Gy-1(95%CI:0.97-1.26),α/β=23.9 Gy(95%CI:8.9-38.9)。
- OERI=1.08(95%CI:1.00-1.41),OERH=1.01(95%CI:1.00-1.44)。
临床怎么用
- 该模型可用于综合光子放疗与碳离子放疗在早期肺癌中的临床经验,辅助比较不同分次方案下的生物效应。
- 推导的RBE随分次剂量和分次数变化,提示碳离子放疗方案设计需考虑分次依赖的RBE。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: Carbon ion radiation therapy (CIRT) is recognized as an effective alternative treatment modality for early stage lung cancer, but a quantitative understanding of relative biological effectiveness (RBE) compared to photon therapy is lacking. In this work, a mechanistic tumor response model previously validated for lung photon radiotherapy was used to estimate the RBE of CIRT compared to photon radiotherapy, as a function of dose and the fractionation schedule. MATERIALS AND METHODS: Clinical outcome data of 9 patient cohorts (394 patients) treated with CIRT for early stage lung cancer, representing all published data, were included. Fractional dose, number of fractions, treatment schedule, and local control rates were used for model simulations relative to standard photon outcomes. Four parameters were fitted: α, α/β, and the oxygen enhancement ratios of cells either accessing only glucose, not oxygen (OERI), or cells dying from starvation (OERH). The resulting dose-response relationship of CIRT was compared with the previously determined dose-response relationship of photon radiotherapy for lung cancer, and an RBE of CIRT was derived. RESULTS: Best-fit CIRT parameters were: α = 1.12 Gy-1 [95%-CI: 0.97-1.26], α/β = 23.9 Gy [95%-CI: 8.9-38.9], and the oxygen induced radioresistance of hypoxic cell populations were characterized by OERI = 1.08 [95%-CI: 1.00-1.41] (cells lacking oxygen but not glucose), and OERH = 1.01 [95%-CI: 1.00-1.44] (cells lacking oxygen and glucose). Depending on dose and fractionation, the derived RBE ranges from 2.1 to 1.5, with decreasing values for larger fractional dose and fewer number of fractions. CONCLUSION: Fitted radiobiological parameters were consistent with known carbon in vitro radiobiology, and the resulting dose-response curve well-fitted the reported data over a wide range of dose-fractionation schemes. The same model, with only a few fitted parameters of clear mechanistic meaning, thus synthesizes both photon radiotherapy and CIRT clinical experience with early stage lung tumors.
引用
- Jeong J, Taasti VT, Jackson A, et al. The relative biological effectiveness of carbon ion radiation therapy for early stage lung cancer. Radiother Oncol. 2020. PMID: 32976878. doi:10.1016/j.radonc.2020.09.027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。